Astral SteriTech Private Ltd. – FDA 483, Jun 20, 2023
An FDA inspection of Astral SteriTech Private Ltd. in Vadodara, India, a sterile drug manufacturer, revealed four significant observations. The firm exhibited inadequate aseptic processing controls, including deficient cleaning and disinfection, and unreliable environmental monitoring data that led to a product recall. Further issues included poor facility maintenance in classified areas and a lack of validation for aseptic processes and sterilization, indicating severe breakdowns in quality control and manufacturing practices.
ID · 192e0ddf-46c2-4cfd-91b1-e7bdbf2ddbd8
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.